The Super Cluster Collimator: Realistic low-dose in vivo imaging

Image Ac-225, At-211 and other challenging radionuclides at administered activities consistent with true preclinical theranostic dosing.
The Super Cluster Collimator enables in vivo imaging at extremely low activity levels, allowing researchers to study biodistribution and therapeutic behavior under biologically relevant conditions, not artificially inflated imaging doses.